Cardiac K(ATP) channels and ischemic preconditioning: Current perspectives

Canadian Journal of Cardiology

Volumn 15, Issue 10, 1999, Pages 1123-1130

  Light, Peter E ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Ischemia

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; CROMAKALIM; DIACYLGLYCEROL; DIAZOXIDE; ENDOTHELIN; GLIBENCLAMIDE; NORADRENALIN; OPIATE RECEPTOR; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PINACIDIL; POTASSIUM; POTASSIUM CHANNEL; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

DRUG ANTAGONISM; DRUG SENSITIVITY; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE EXCITABILITY; HEART PROTECTION; HUMAN; MITOCHONDRION; NEUROPROTECTION; REVIEW; FEMALE; HEART MUSCLE ISCHEMIA; MALE; METABOLISM; PATHOPHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL ISCHEMIA; NEUROTRANSMITTER AGENTS;

EID: 0033238003     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Hearse DJ. Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res 1995;30:1-17.
2. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-33.
3. Opie LH. Modulation of ischemia by regulation of the ATP-sensitive potassium channel. Cardiovasc Drugs Ther 1993;7(Suppl 3):507-13.
4. ATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 1997;75:309-15.
5. Liu Y, Sato T, O'Rourke B, Marban E. Miotochondrial ATP-dependent potassium channels: Novel effectors of cardioprotection? Circulation 1998;97:2463-9.
6. + channels by protein kinase C. Circ Res 1998;83:110-4.
7. + channels and myocardial preconditioning. Circ Res 1999;84:973-9.
8. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 1993;27:542-50.
9. Cohen MV, Downey JM. Myocardial preconditioning promises to be a novel approach to the treatment of ischemic heart disease. Annu Rev Med 1996;47:21-9.
10. Schwarz ER, Whyte, WS, Kloner RA. Ischemic preconditioning. Curr Opin Cardiol 1997;12:475-81.
11. Ishida I, Yarimizu K, Gute DC, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 1997;8:86-94.
12. Richard V, Kaeffer N, Thuillez C. Delayed protection of the human heart - from pathophysiology to therapeutic applications. Fundam Clin Pharmacol 1996;10:409-15.
13. Hoag JB, Qian YZ, Nayeem MA, D'Angelo M, Kukreja RC. ATP-sensitive potassium channel mediates delayed ischemic protection by heat stress in rabbit heart. Am J Physiol 1997;273:H2458-64.
14. Lawson CS. Does ischemic preconditioning occur in the human heart? Cardiovasc Res 1994;28:1461-6.
15. Edwards RJ, Marber MS. Myocardial preconditioning: mechanisms and man. Int J Clin Pract 1999;52:395-401.
16. Parratt JR. Protection of the heart by ischemic preconditioning: mechanisms and possibilities for pharmacological exploitation. Trends Pharmacol Sci 1994;15:19-25.
17. Grover GJ, McCullough JR, Henry DE, Conder ML, Sleph PG. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. J Pharmacol Exp Ther 1989;251:98-104.
18. ATP channels and ischaemic preconditioning. Cardiovasc Res 1994;28:783-7.
19. Yao Z, Gross G. Acetylcholine mimics ischemic preconditioning via a glibenclamide-sensitive mechanism in dogs. Am J Physiol 1993;264:H2221-5
20. Garrat KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Homes DR Jr. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999;33:119-24.
21. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res 1998;40:9-22.
22. Brooks G, Hearse DJ. Role of protein kinase C in ischemic preconditioning: Player or spectator. Circ Res 1996;79:627-30.
23. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-90.
24. Parker PJ, Kour G, Marais RM, et al. Protein kinase C - a family affair. Mol Cell Endocrinol 1989;65:1-11.
25. Kikkawa U, Kishimoto A, Nishizuka Y. The protein kinase C family: heterogeneity and its implications. Annu Rev Biochem 1989;58:31-44.
26. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-96.
27. Steinberg SF, Goldberg M, Rybin VO. Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 1995;27:141-53.
28. Hu K, Duan D, Nattel S. Protein kinase C mediated activation of ATP-sensitive potassium current - the missing link in ischemic preconditioning. Circulation 1995;92:1251.
29. + current in human and rabbit ventricular myocytes. Circ Res 1996;78:492-8.
30. ATP channel in isolated rat heart. J Mol Cell Cardiol 1995;27:Tu113. (Abst)
31. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26:661-8.
32. 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-85.
33. + channel? Circ Res 1995;77:1030-5.
34. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-52.
35. ATP) channels. J Mol Cell Cardiol 1995;27:Tu068. (Abst)
36. Light PE, Sabir AA, Allen BG, Walsh MP, French RJ. Protein kinase C-induced changes in the stoichiometry of ATP binding activate cardiac ATP-sensitive potassium channels: A possible mechanistic link to ischemic preconditioning. Circ Res 1996;79:399-406.
37. Light PE, Allen BG, Walsh MP, French RJ. Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase. Biochemistry 1995;34:7252-7.
38. Weinbrenner C, Baines CP, Liu GS, et al. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after the onset of ischemia. Circulation 1998;98:899-905.
39. Downey JM, Liu GS, Thornton JD. Adenosine and the anti-infarct effects of preconditioning. Cardiovasc Res 1993;27:3-8.
40. Liu Y, Tsuchida A, Cohen MV. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995;27:883-92.
41. Hide EJ, Piper J, Theimermann C. Endothelin-I-induced reduction in myocardial infarct size by activation of ATP-sensitive potassium channels in a rabbit model of myocardial ischemia and reperfusion. Br J Pharmacol 1995;116:2597-602.
42. ATP channels in the isolated rat heart. Cardiovasc Res 1996;32:920-9.
43. Miki T, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem 1998;186:3-12.
44. + channels in cardiac muscle. Nature 1983;305:147-8.
45. + channels protect the myocardium against ischemia/reperfusion damage. Circ Res 1991;69:571-81.
46. + channels in cardiac ischemia: An endogenous mechanism for protection of the heart. Cardiovasc Drugs Ther 1993;7(Suppl 3):527-37.
47. Nichols CG, Lederer WJ. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 1991;261:H1675-86.
48. ATP channels. Science 1998;282:1138-41.
49. ATP channels. Science 1998;282:1141-4.
50. Light P. Regulation of ATP-sensitive potassium channels by phosphorylation. Biochim Biophys Acta 1996;1286:65-73.
51. + channel. Prog Neurobiol 1993;41:21-30.
52. De Weille JR, Lazdunski M. Regulation of the ATP-sensitive potassium channel. In: Narahashi T, ed. Ion Channels, 2nd edn. New York: Plenum Press, 1990:205-22.
53. ATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 1995;270:1166-70.
54. + channels. Neuron 1996;16:1011-7.
55. ATP channels. Functional identity with the native channels from the sarcolemma of human ventricle cells. Circ Res 1998;83:1132-43.
56. Babenko AP, Aguilar-Bryan L, Bryan J. A view of SUR/Kir6.X KATP channels. Annu Rev Physiol 1998;60:667-87.
57. + channel. Can J Cardiol 1998;14(Suppl F):81F. (Abst)
58. ATP channel as receptor for potassium channel openers. J Biol Chem 1996;271:8796-9.
59. + current during hypoxia: Correlation with tissue ATP levels. Am J Physiol 1991;261:H671-6
60. + channel modification by metabolic inhibition in isolated guinea-pig ventricular myocytes. J Physiol (Lond) 1993;465:163-79.
61. + channels. Cardiovasc Drugs Ther 1993;7(Suppl 3):499-505.
62. Allen DG, Orchard CH. Myocardial contractile function during ischemia and hypoxia. Circ Res 1987;60:153-68.
63. Lederer WJ, Nichols CG, Smith GL. The mechanism of early contractile failure of isolated rat ventricular myocytes subjected to complete metabolic inhibition. J Physiol (Lond) 1989;413:329-49.
64. Goldhaber JI, Parker JM, Weiss JN. Mechanisms of excitation-contraction coupling failure during metabolic inhibition in guinea-pig ventricular myocytes. J Physiol (Lond) 1991;443:371-86.
65. + channel subunits confer resistance to chemical hypoxia-reoxygenation injury. Circulation 1998;98:1548-55.
66. +-ATPase modulates ischemic preconditioning. Circulation 1998;98:2905-10.
67. Diaz, RJ, Losito VA, Mao GD, Ford MK, Backx PH, Wilson GJ. Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res 1999;84:763-75.
68. Graver GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res 1995;30:731-8.
69. 2+ overload injury in rat myocardium. Circ Res 1999;84:1156-65.
70. Garlid KD. Cation transport in the mitochondria. Biochim Biophys Acta 1996;1275:123-6.
71. Ferrari R. The role of mitochondria in ischemic heart disease. J Cardiovasc Pharmacol 1998;28(Suppl 1):S1-10.
72. + channels modulate cardiac mitochondrial function. Am J Physiol 1998;275:H1567-76.
73. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300.
74. Reimer KA. The slowing of ischemic energy demand in preconditioned myocardium. Ann NY Acad Sci 1996;793:13-26.
75. + channels. Int J Cardiol 1998;67:225-36.
76. Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol 1995;269:H1767-75.
77. Xu ZL, Endoh H, Ishihata A, Takahashi E, Doi K. Effect of ischemic preconditioning on myocardial oxygen consumption during ischemia. J Mol Cell Cardiol 1998;30:2165-74.
78. Jenkins DP, Steare SE, Yellon DM. Preconditioning the human myocardium: recent advances and aspirations for the development of a new means of cardioprotection in clinical practice. Cardiovasc Drugs Ther 1999;9:739-47.
79. DiFrancesco D, Noble D. A model of cardiac electrical activity incorporating ionic pumps and concentration changes. Philos Trans R Soc Lond B Biol Sci 1985;307:353-98.